Immune checkpoint modulation enhances HIV-1 antibody induction

Immune checkpoint modulation enhances HIV-1 antibody induction

Eliciting protective titers of HIV-1 broadly neutralizing antibodies (bnAbs) is a goal of HIV-1 vaccine development, but current vaccine strategies have yet to induce bnAbs in humans. Many bnAbs isolated from HIV-1-infected individuals are encoded by immunoglobulin gene rearrangments with infrequent...

Full description

Bibliographic Details
Main Authors:	Bradley, T, Kuraoka, M, Yeh, C-H, Ogbe, A, Borrow, P, Et al.
Format:	Journal article
Language:	English
Published:	Springer Nature 2020

Similar Items

RAB11FIP5 expression and altered natural killer cell function are associated with induction of HIV broadly neutralizing antibody responses
by: Bradley, T, et al.
Published: (2018)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
by: Garnett Kelsoe, et al.
Published: (2013-12-01)

Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies
by: Moody, M, et al.
Published: (2016)

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination
by: Nel, C, et al.
Published: (2024)

Innate immunity in acute HIV-1 infection
by: Borrow, P
Published: (2011)

Innate immunity in acute HIV-1 infection.
by: Borrow, P
Published: (2011)

Immune checkpoints and the HIV-1 reservoir: proceed with caution
by: Rikke Olesen, et al.
Published: (2016-07-01)

Manipulating immune checkpoint signalling pathways with antibodies
by: Paluch, C
Published: (2019)

Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1
by: Catarina E. Hioe, et al.
Published: (2023-10-01)

Innate immune responses in primary HIV-1 infection.
by: Borrow, P, et al.
Published: (2008)

HIV-1 induction of macrophage immune mediators
by: Dacon, C
Published: (2019)

The immune response to human immunodeficiency virus type 1 (HIV-1)
by: Turnbull, E, et al.
Published: (2005)

Can Exercise Enhance the Efficacy of Checkpoint Inhibition by Modulating Anti-Tumor Immunity?
by: Christina Brummer, et al.
Published: (2023-09-01)

Subordinate effect of -21M HLA-B dimorphism on NK cell repertoire diversity and function in HIV-1 infected individuals of African origin
by: Cubero, EM, et al.
Published: (2020)

Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance
by: Cirelli, Kimberly M., et al.
Published: (2020)

Corrigendum: Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1
by: Catarina E. Hioe, et al.
Published: (2023-11-01)

Gut microbiome in modulating immune checkpoint inhibitors
by: Xiang Li, et al.
Published: (2022-08-01)

Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors
by: Jinglong Huang, et al.
Published: (2023-10-01)

A stronger innate immune response during hyperacute HIV-1 infection is associated with acute retroviral syndrome
by: Hassan, AS, et al.
Published: (2021)

Targeting Immune Checkpoint Molecules to Eliminate Latent HIV
by: Zoe Boyer, et al.
Published: (2018-10-01)

Seronegative antibody‐mediated neurology after immune checkpoint inhibitors
by: Wilson, R, et al.
Published: (2018)

1187 Antibody-lectin bispecifics for glyco-immune checkpoint blockade
by: Nicholas Riley, et al.
Published: (2023-11-01)

A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME
by: Xuejun Xiao, et al.
Published: (2022-07-01)

IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection
by: Moreno-Cubero, E, et al.
Published: (2024)

Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies
by: Anissa S. H. Chan, et al.
Published: (2022-05-01)

Gut microbiome modulates efficacy of immune checkpoint inhibitors
by: Ming Yi, et al.
Published: (2018-03-01)

Epigenetics modulates the complexity of the response to Immune Checkpoint Blockade
by: Isabel Barragan
Published: (2020-10-01)

Development of the antibody response in acute HIV-1 infection.
by: Aasa-Chapman, M, et al.
Published: (2004)

The promise and challenge of anti-HIV cellular immunity.
by: Borrow, P, et al.
Published: (2006)

Immune Checkpoint Glycoproteins Have Polymorphism: Are Monoclonal Antibodies Too Specific?
by: Mehrsa Jalalizadeh, et al.
Published: (2023-01-01)

Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
by: Katsiaryna Marhelava, et al.
Published: (2019-11-01)

Immune checkpoint-targeted antibodies: a room for dose and schedule optimization?
by: Christophe Maritaz, et al.
Published: (2022-01-01)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
by: Nicholas Gravbrot, et al.
Published: (2019-10-01)

Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
by: Borrow, P, et al.
Published: (2017)

IL-1β mediates the induction of immune checkpoint regulators IDO1 and PD-L1 in lung adenocarcinoma cells
by: Afshan Fathima Nawas, et al.
Published: (2023-11-01)

Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy
by: Lisa K. Puntigam, et al.
Published: (2020-07-01)

Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction.
by: Bachmann, M, et al.
Published: (1994)

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
by: Iris Koopmans, et al.
Published: (2018-08-01)

27 HIV-associated gastrointestinal microbial dysbiosis influences the efficacy of anti-HIV immunity by immune checkpoint blockade
by: I.N. SahBandar, et al.
Published: (2017-07-01)

HIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages
by: Hisashi Akiyama, et al.
Published: (2020-06-01)